NCT04346888 2023-03-08
A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 2 Completed
Harbour BioMed (Guangzhou) Co. Ltd.
Harbour BioMed (Guangzhou) Co. Ltd.
Harbour BioMed (Guangzhou) Co. Ltd.